APPLIED GENETIC TECHNOLOGIES CORP Quarterly Debt-to-equity in % from Q4 2014 to Q3 2022

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Applied Genetic Technologies Corp quarterly Debt-to-equity history and growth rate from Q4 2014 to Q3 2022.
  • Applied Genetic Technologies Corp Debt-to-equity for the quarter ending September 30, 2022 was 108 %, a 120% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2022 108 +59.1 +120% Sep 30, 2022
Q2 2022 80.6 +32.9 +69.1% Jun 30, 2022
Q1 2022 64.3 +18.4 +40.1% Mar 31, 2022
Q4 2021 51.2 +8.05 +18.6% Dec 31, 2021
Q3 2021 49.4 +12.2 +32.8% Sep 30, 2021
Q2 2021 47.7 +16.5 +52.9% Jun 30, 2021
Q1 2021 45.9 +20.9 +83.9% Mar 31, 2021
Q4 2020 43.2 +21.1 +96% Dec 31, 2020
Q3 2020 37.2 +13.1 +54.4% Sep 30, 2020
Q2 2020 31.2 +1.14 +3.8% Jun 30, 2020
Q1 2020 24.9 -5.01 -16.7% Mar 31, 2020
Q4 2019 22 -8.8 -28.5% Dec 31, 2019
Q3 2019 24.1 -0.82 -3.29% Sep 30, 2019
Q2 2019 30 +10.7 +55.1% Jun 30, 2019
Q1 2019 29.9 +8.31 +38.4% Mar 31, 2019
Q4 2018 30.8 +5.58 +22.1% Dec 31, 2018
Q3 2018 24.9 -6.05 -19.5% Sep 30, 2018
Q2 2018 19.4 -19.3 -49.9% Jun 30, 2018
Q1 2018 21.6 -26 -54.5% Mar 31, 2018
Q4 2017 25.3 -33.3 -56.8% Dec 31, 2017
Q3 2017 31 -40.4 -56.6% Sep 30, 2017
Q2 2017 38.6 -48.7 -55.8% Jun 30, 2017
Q1 2017 47.6 -27.9 -37% Mar 31, 2017
Q4 2016 58.5 +1.53 +2.69% Dec 31, 2016
Q3 2016 71.4 +38.2 +115% Sep 30, 2016
Q2 2016 87.3 +83.5 +2195% Jun 30, 2016
Q1 2016 75.5 +72.1 +2159% Mar 31, 2016
Q4 2015 57 +52.1 +1057% Dec 31, 2015
Q3 2015 33.1 Sep 30, 2015
Q2 2015 3.8 Jun 30, 2015
Q1 2015 3.34 Mar 31, 2015
Q4 2014 4.93 Dec 31, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.